Invesco Biotechnology & Genome ETF
PBE
PBE
74 hedge funds and large institutions have $93.2M invested in Invesco Biotechnology & Genome ETF in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
Holders
74
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$32.7M | |
| 2 | +$1.38M | |
| 3 | +$1.27M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$669K |
| 5 |
Morgan Stanley
New York
|
+$558K |
Top Sellers
| 1 | -$730K | |
| 2 | -$645K | |
| 3 | -$454K | |
| 4 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
-$353K |
| 5 |
TAM
Trillium Asset Management
Boston,
Massachusetts
|
-$215K |